CRISPR genome editing therapy lowers blood fats in early trial
A single infusion of an experimental CRISPR/Cas9 genome editing therapy reduced triglyceride levels by an average of 63 percent in people with severely elevated blood fats...
A single infusion of an experimental CRISPR/Cas9 genome editing therapy reduced triglyceride levels by an average of 63 percent in people with severely elevated blood fats...
by Evie Ribeiro
Children aged five and older with severe sickle cell disease or transfusion-dependent beta-thalassaemia can now receive cell-based gene therapy Casgevy after the UK extended its authorisation to include eligible younger children...
Dr Desislava Staneva reviews The Second Creation, exploring the science behind Dolly the sheep, the history of cloning and how genome editing has changed the field…
by Yan Lau
Switching back on a gene that is normally silenced early in development has improved features of severe alpha-thalassaemia in mice and restored globin production in cells from patients...
The US Food and Drug Administration has outlined a framework that could allow multiple related, patient-specific genome editing therapies to be covered by a single approval, for patients with different genetic variants of the same gene...
Prime editing – a type of genome editing – has been used to alter DNA directly inside a person's body for the first time...
A genome editing technique has corrected a disease-causing mutation in blood stem cells taken from a patient with a rare and severe immune disorder...
A new genome editing method allows long DNA fragments to be integrated into precise positions within the genome of cells...
The discovery of a new gene-targeting system used by viruses to fend off competitors gives a glimpse into the possible evolutionary origin of CRISPR, and may offer new opportunities for genome editing technologies...
Base editing can efficiently alter the DNA of human embryos, but it can also result in unintended genomic changes....
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.